BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ryu S, Chang Y, Kim DI, Kim WS, Suh BS. gamma-Glutamyltransferase as a predictor of chronic kidney disease in nonhypertensive and nondiabetic Korean men. Clin Chem. 2007;53:71-77. [PMID: 17110470 DOI: 10.1373/clinchem.2006.078980] [Cited by in Crossref: 129] [Cited by in F6Publishing: 122] [Article Influence: 8.1] [Reference Citation Analysis]
Number Citing Articles
1 Hashimoto Y, Hamaguchi M, Fukuda T, Ohbora A, Kojima T, Fukui M. Fatty liver as a risk factor for progression from metabolically healthy to metabolically abnormal in non-overweight individuals. Endocrine 2017;57:89-97. [DOI: 10.1007/s12020-017-1313-6] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 5.6] [Reference Citation Analysis]
2 Chang Y, Ryu S, Suh BS, Yun KE, Kim CW, Cho SI. Impact of BMI on the incidence of metabolic abnormalities in metabolically healthy men. Int J Obes (Lond) 2012;36:1187-94. [PMID: 22158268 DOI: 10.1038/ijo.2011.247] [Cited by in Crossref: 61] [Cited by in F6Publishing: 62] [Article Influence: 5.5] [Reference Citation Analysis]
3 Xiao Y, Yang H, Lu J, Li D, Xu C, Risch HA. Serum gamma-glutamyltransferase and the overall survival of metastatic pancreatic cancer.BMC Cancer. 2019;19:1020. [PMID: 31664937 DOI: 10.1186/s12885-019-6250-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
4 Targher G, Bertolini L, Rodella S, Zoppini G, Lippi G, Day C, Muggeo M. Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and proliferative/laser-treated retinopathy in type 2 diabetic patients. Diabetologia. 2008;51:444-450. [PMID: 18058083 DOI: 10.1007/s00125-007-0897-4] [Cited by in Crossref: 198] [Cited by in F6Publishing: 174] [Article Influence: 13.2] [Reference Citation Analysis]
5 Strasak AM, Pfeiffer RM, Klenk J, Hilbe W, Oberaigner W, Gregory M, Concin H, Diem G, Pfeiffer KP, Ruttmann E, Ulmer H; Vorarlberg Health Monitoring and Promotion Program Study Group. Prospective study of the association of gamma-glutamyltransferase with cancer incidence in women. Int J Cancer. 2008;123:1902-1906. [PMID: 18688855 DOI: 10.1002/ijc.23714] [Cited by in Crossref: 63] [Cited by in F6Publishing: 61] [Article Influence: 4.5] [Reference Citation Analysis]
6 Hashimoto Y, Okamura T, Hamaguchi M, Obora A, Kojima T, Fukui M. Creatinine to Body Weight Ratio Is Associated with Incident Diabetes: Population-Based Cohort Study. J Clin Med 2020;9:E227. [PMID: 31952309 DOI: 10.3390/jcm9010227] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Lee DH, Buijsse B, Steffen L, Holtzman J, Luepker R, Jacobs DR Jr. Association between serum gamma-glutamyltransferase and cardiovascular mortality varies by age: the Minnesota Heart Survey. Eur J Cardiovasc Prev Rehabil 2009;16:16-20. [PMID: 18753951 DOI: 10.1097/HJR.0b013e32830aba5c] [Cited by in Crossref: 38] [Cited by in F6Publishing: 12] [Article Influence: 2.9] [Reference Citation Analysis]
8 Fargion S, Porzio M, Fracanzani AL. Nonalcoholic fatty liver disease and vascular disease: State-of-the-art. World J Gastroenterol 2014; 20(37): 13306-13324 [PMID: 25309067 DOI: 10.3748/wjg.v20.i37.13306] [Cited by in CrossRef: 118] [Cited by in F6Publishing: 116] [Article Influence: 14.8] [Reference Citation Analysis]
9 Sepulveda J. Challenges in Routine Clinical Chemistry Analysis. Accurate Results in the Clinical Laboratory. Elsevier; 2013. pp. 131-48. [DOI: 10.1016/b978-0-12-415783-5.00009-8] [Cited by in Crossref: 6] [Article Influence: 0.7] [Reference Citation Analysis]
10 Chang Y, Ryu S, Sung E, Jang Y. Higher concentrations of alanine aminotransferase within the reference interval predict nonalcoholic fatty liver disease. Clin Chem. 2007;53:686-692. [PMID: 17272484 DOI: 10.1373/clinchem.2006.081257] [Cited by in Crossref: 147] [Cited by in F6Publishing: 134] [Article Influence: 9.8] [Reference Citation Analysis]
11 Whitfield JB. Serum γ-Glutamyltransferase and Risk of Disease. Clinical Chemistry 2007;53:1-2. [DOI: 10.1373/clinchem.2006.080911] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 1.5] [Reference Citation Analysis]
12 Claessen H, Brenner H, Drath C, Arndt V. Gamma-glutamyltransferase and disability pension: a cohort study of construction workers in Germany. Hepatology 2010;51:482-90. [PMID: 19967717 DOI: 10.1002/hep.23324] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
13 Mantovani A, Zusi C, Dalbeni A, Grani G, Buzzetti E. Risk of Kidney Dysfunction IN Nafld. CPD 2020;26:1045-61. [DOI: 10.2174/1381612825666191026113119] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
14 Chen T, Ren Y, Gao Y, Tian H. Serum Gamma-Glutamyl Transferase and Ferritin Synergistically Associated with the Rate of Chronic Kidney Disease. Dis Markers 2017;2017:9765259. [PMID: 28659657 DOI: 10.1155/2017/9765259] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
15 Khan DA, Qayyum S, Saleem S, Khan FA. Lead-induced oxidative stress adversely affects health of the occupational workers. Toxicol Ind Health 2008;24:611-8. [PMID: 19106128 DOI: 10.1177/0748233708098127] [Cited by in Crossref: 60] [Cited by in F6Publishing: 52] [Article Influence: 4.6] [Reference Citation Analysis]
16 Koseoglu HI, Altunkas F, Demir O, Doruk S, Etikan I, Benli I. Serum levels of gamma-glutamyl transferase are associated with cardiovascular disease in obstructive sleep apnea syndrome. Ann Saudi Med 2013;33:584-90. [PMID: 24413863 DOI: 10.5144/0256-4947.2013.584] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
17 Fan Y, Jin X, Man C, Gong D. Association of serum gamma-glutamyltransferase with chronic kidney disease risk: a meta-analysis. Free Radical Research 2018;52:819-25. [DOI: 10.1080/10715762.2018.1492120] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
18 Lee W, Ryoo J, Suh BS, Lee J, Kim J. Association of coronary artery calcification and serum gamma-glutamyl transferase in Korean. Atherosclerosis 2013;226:269-74. [DOI: 10.1016/j.atherosclerosis.2012.10.059] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
19 Fassett RG, Venuthurupalli SK, Gobe GC, Coombes JS, Cooper MA, Hoy WE. Biomarkers in chronic kidney disease: a review. Kidney Int 2011;80:806-21. [PMID: 21697815 DOI: 10.1038/ki.2011.198] [Cited by in Crossref: 251] [Cited by in F6Publishing: 215] [Article Influence: 22.8] [Reference Citation Analysis]
20 Okamura T, Hashimoto Y, Hamaguchi M, Obora A, Kojima T, Fukui M. Low urine pH is a risk for non-alcoholic fatty liver disease: A population-based longitudinal study. Clinics and Research in Hepatology and Gastroenterology 2018;42:570-6. [DOI: 10.1016/j.clinre.2018.06.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
21 Hamaguchi M, Kojima T, Ohbora A, Takeda N, Fukui M, Kato T. Aging is a risk factor of nonalcoholic fatty liver disease in premenopausal women. World J Gastroenterol 2012; 18(3): 237-243 [PMID: 22294826 DOI: 10.3748/wjg.v18.i3.237] [Cited by in CrossRef: 70] [Cited by in F6Publishing: 69] [Article Influence: 7.0] [Reference Citation Analysis]
22 Saijo Y, Okada H, Hamaguchi M, Okamura T, Hashimoto Y, Majima S, Sennmaru T, Nakanishi N, Ushigome E, Asano M, Yamazaki M, Fukui M. Association between the frequency of toothbrushing and lifestyle in people with type 2 diabetes mellitus: at the baseline date of the Kamogawa-DM cohort study. J Clin Biochem Nutr 2021;69:294-8. [PMID: 34857992 DOI: 10.3164/jcbn.21-15] [Reference Citation Analysis]
23 Suh YJ, Park SK, Choi JM, Ryoo JH. The clinical importance of serum γ-glutamyltransferase level as an early predictor of obesity development in Korean men. Atherosclerosis 2013;227:437-41. [PMID: 23395520 DOI: 10.1016/j.atherosclerosis.2013.01.029] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
24 Takahashi S, Tanaka M, Furuhashi M, Moniwa N, Koyama M, Higashiura Y, Osanami A, Gocho Y, Ohnishi H, Numata K, Hisasue T, Hanawa N, Miura T. Fatty liver index is independently associated with deterioration of renal function during a 10-year period in healthy subjects. Sci Rep 2021;11:8606. [PMID: 33883636 DOI: 10.1038/s41598-021-88025-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
25 Wang Q, Shu X, Dong Y, Zhou J, Teng R, Shen J, Chen Y, Dong M, Zhang W, Huang Y, Xie S, Wei Q, Zhao W, Chen W, Yuan X, Qi X, Wang L. Tumor and serum gamma-glutamyl transpeptidase, new prognostic and molecular interpretation of an old biomarker in gastric cancer. Oncotarget. 2017;8:36171-36184. [PMID: 28404903 DOI: 10.18632/oncotarget.15609] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
26 Kasapoglu B, Turkay C, Yalcın KS, Boga S, Bozkurt A. Increased microalbuminuria prevalence among patients with nonalcoholic fatty liver disease. Renal Failure 2015;38:15-9. [DOI: 10.3109/0886022x.2015.1106845] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
27 Skubera M, Gołąb A, Plicner D, Natorska J, Ząbczyk M, Trojnarska O, Mazurek-Kula A, Smaś-Suska M, Bartczak-Rutkowska A, Podolec P, Tomkiewicz-Pająk L. Properties of Plasma Clots in Adult Patients Following Fontan Procedure: Relation to Clot Permeability and Lysis Time-Multicenter Study. J Clin Med 2021;10:5976. [PMID: 34945271 DOI: 10.3390/jcm10245976] [Reference Citation Analysis]
28 Li G, Shi W, Hug H, Chen Y, Liu L, Yin D. Nonalcoholic fatty liver disease associated with impairment of kidney function in nondiabetes population. Biochem Med (Zagreb). 2012;22:92-99. [PMID: 22384523 DOI: 10.11613/bm.2012.010] [Cited by in Crossref: 20] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
29 Ryu S, Chang Y, Woo HY, Kim SG, Kim DI, Kim WS, Suh BS, Choi NK, Lee JT. Changes in body weight predict CKD in healthy men. J Am Soc Nephrol 2008;19:1798-805. [PMID: 18495960 DOI: 10.1681/ASN.2007121286] [Cited by in Crossref: 52] [Cited by in F6Publishing: 23] [Article Influence: 3.7] [Reference Citation Analysis]
30 Garofalo C, Borrelli S, Minutolo R, Chiodini P, De Nicola L, Conte G. A systematic review and meta-analysis suggests obesity predicts onset of chronic kidney disease in the general population. Kidney Int 2017;91:1224-35. [PMID: 28187985 DOI: 10.1016/j.kint.2016.12.013] [Cited by in Crossref: 86] [Cited by in F6Publishing: 74] [Article Influence: 17.2] [Reference Citation Analysis]
31 Byrne CD, Targher G. NAFLD as a driver of chronic kidney disease. J Hepatol. 2020;72:785-801. [PMID: 32059982 DOI: 10.1016/j.jhep.2020.01.013] [Cited by in Crossref: 56] [Cited by in F6Publishing: 56] [Article Influence: 28.0] [Reference Citation Analysis]
32 Zheng X, Cao C, He Y, Wang X, Wu J, Hu H. Association between nonalcoholic fatty liver disease and incident diabetes mellitus among Japanese: a retrospective cohort study using propensity score matching. Lipids Health Dis 2021;20:59. [PMID: 34130693 DOI: 10.1186/s12944-021-01485-x] [Reference Citation Analysis]
33 Liu YR, Yang NJ, Zhao ML, Tang ZS, Duan JA, Zhou R, Chen L, Sun J, Song ZX, Hu JH, Shi XB. Hypericum perforatum L. Regulates Glutathione Redox Stress and Normalizes Ggt1/Anpep Signaling to Alleviate OVX-Induced Kidney Dysfunction. Front Pharmacol 2021;12:628651. [PMID: 33981220 DOI: 10.3389/fphar.2021.628651] [Reference Citation Analysis]
34 Stojakovic T, Scharnagl H, Trauner M, Pieske B, Wellnitz B, Seelhorst U, Schilling D, Winkelmann BR, Boehm BO, März W. Serum gamma-glutamyl transferase and mortality in persons undergoing coronary angiography—The Ludwigshafen Risk and Cardiovascular Health Study. Atherosclerosis 2010;208:564-71. [DOI: 10.1016/j.atherosclerosis.2009.07.026] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 2.3] [Reference Citation Analysis]
35 Fukuda T, Hamaguchi M, Kojima T, Hashimoto Y, Ohbora A, Kato T, Nakamura N, Fukui M. The impact of non-alcoholic fatty liver disease on incident type 2 diabetes mellitus in non-overweight individuals. Liver Int 2016;36:275-83. [DOI: 10.1111/liv.12912] [Cited by in Crossref: 76] [Cited by in F6Publishing: 75] [Article Influence: 10.9] [Reference Citation Analysis]
36 Armstrong MJ, Adams LA, Canbay A, Syn WK. Extrahepatic complications of nonalcoholic fatty liver disease. Hepatology. 2014;59:1174-1197. [PMID: 24002776 DOI: 10.1002/hep.26717] [Cited by in Crossref: 301] [Cited by in F6Publishing: 281] [Article Influence: 37.6] [Reference Citation Analysis]
37 Kim CW, Chang Y, Sung E, Shin H, Ryu S. Serum ferritin levels predict incident non-alcoholic fatty liver disease in healthy Korean men. Metabolism. 2012;61:1182-1188. [PMID: 22386931 DOI: 10.1016/j.metabol.2012.01.007] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.3] [Reference Citation Analysis]
38 Pallayova M, Taheri S. Non-alcoholic fatty liver disease in obese adults: clinical aspects and current management strategies. Clin Obes. 2014;4:243-253. [PMID: 25825857 DOI: 10.1111/cob.12068] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
39 Pan L, Zhang H, Huang Z, Sun Q, Chen Z, Li Z, Yang S, Li X, Li X. Intrahepatic triglyceride content is independently associated with chronic kidney disease in obese adults: A cross-sectional study. Metabolism 2015;64:1077-85. [DOI: 10.1016/j.metabol.2015.06.003] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 2.6] [Reference Citation Analysis]
40 Franzini M, Bramanti E, Ottaviano V, Ghiri E, Scatena F, Barsacchi R, Pompella A, Donato L, Emdin M, Paolicchi A. A high performance gel filtration chromatography method for γ-glutamyltransferase fraction analysis. Analytical Biochemistry 2008;374:1-6. [DOI: 10.1016/j.ab.2007.10.025] [Cited by in Crossref: 45] [Cited by in F6Publishing: 37] [Article Influence: 3.2] [Reference Citation Analysis]
41 Shen Z, Xing J, Wang Q, Faheem A, Ji X, Li J, Bian W, Jiang Z, Li X, Xue F, Liu J. Association between serum γ-glutamyltransferase and chronic kidney disease in urban Han Chinese: a prospective cohort study. Int Urol Nephrol 2017;49:303-12. [DOI: 10.1007/s11255-016-1429-2] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
42 Bonora E, Targher G. Increased risk of cardiovascular disease and chronic kidney disease in NAFLD. Nat Rev Gastroenterol Hepatol. 2012;9:372-381. [PMID: 22565095 DOI: 10.1038/nrgastro.2012.79] [Cited by in Crossref: 77] [Cited by in F6Publishing: 71] [Article Influence: 7.7] [Reference Citation Analysis]
43 Reo YJ, Dai M, Yang YJ, Ahn KH. Cell-Membrane-Localizing, Two-Photon Probe for Ratiometric Imaging of γ-Glutamyl Transpeptidase in Cancerous Cells and Tissues. Anal Chem 2020;92:12678-85. [PMID: 32808765 DOI: 10.1021/acs.analchem.0c03013] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 4.5] [Reference Citation Analysis]
44 Targher G, Chonchol M, Zoppini G, Abaterusso C, Bonora E. Risk of chronic kidney disease in patients with non-alcoholic fatty liver disease: Is there a link? Journal of Hepatology 2011;54:1020-9. [DOI: 10.1016/j.jhep.2010.11.007] [Cited by in Crossref: 101] [Cited by in F6Publishing: 99] [Article Influence: 9.2] [Reference Citation Analysis]
45 Hamaguchi M, Hashimoto Y, Obora A, Kojima T, Fukui M. Non-alcoholic fatty liver disease with obesity as an independent predictor for incident gastric and colorectal cancer: a population-based longitudinal study. BMJ Open Gastroenterol 2019;6:e000295. [PMID: 31275587 DOI: 10.1136/bmjgast-2019-000295] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 5.7] [Reference Citation Analysis]
46 Strasak AM, Rapp K, Brant LJ, Hilbe W, Gregory M, Oberaigner W, Ruttmann E, Concin H, Diem G, Pfeiffer KP, Ulmer H; VHM&PP Study Group. Association of gamma-glutamyltransferase and risk of cancer incidence in men: a prospective study. Cancer Res. 2008;68:3970-3977. [PMID: 18483283 DOI: 10.1158/0008-5472.can-07-6686] [Cited by in Crossref: 80] [Cited by in F6Publishing: 39] [Article Influence: 5.7] [Reference Citation Analysis]
47 Nagel G, Zitt E, Peter R, Pompella A, Concin H, Lhotta K. Body mass index and metabolic factors predict glomerular filtration rate and albuminuria over 20 years in a high-risk population. BMC Nephrol 2013;14:177. [PMID: 23962027 DOI: 10.1186/1471-2369-14-177] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
48 Feng RN, Du SS, Wang C, Li YC, Liu LY, Guo FC, Sun CH. Lean-non-alcoholic fatty liver disease increases risk for metabolic disorders in a normal weight Chinese population. World J Gastroenterol 2014; 20(47): 17932-17940 [PMID: 25548491 DOI: 10.3748/wjg.v20.i47.17932] [Cited by in CrossRef: 103] [Cited by in F6Publishing: 92] [Article Influence: 12.9] [Reference Citation Analysis]
49 Bang KB, Cho YK. Comorbidities and Metabolic Derangement of NAFLD. J Lifestyle Med. 2015;5:7-13. [PMID: 26528424 DOI: 10.15280/jlm.2015.5.1.7] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 4.0] [Reference Citation Analysis]
50 Oksuz F, Yarlioglues M, Cay S, Celik IE, Mendi MA, Kurtul A, Cankurt T, Kuyumcu S, Canpolat U, Turak O. Predictive Value of Gamma-Glutamyl Transferase Levels for Contrast-Induced Nephropathy in Patients With ST-Segment Elevation Myocardial Infarction Who Underwent Primary Percutaneous Coronary Intervention. Am J Cardiol 2015;116:711-6. [PMID: 26116992 DOI: 10.1016/j.amjcard.2015.05.042] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
51 Chang Y, Ryu S, Sung E, Woo HY, Oh E, Cha K, Jung E, Kim WS. Nonalcoholic fatty liver disease predicts chronic kidney disease in nonhypertensive and nondiabetic Korean men. Metabolism. 2008;57:569-576. [PMID: 18328362 DOI: 10.1016/j.metabol.2007.11.022] [Cited by in Crossref: 88] [Cited by in F6Publishing: 86] [Article Influence: 6.3] [Reference Citation Analysis]
52 Ryu S, Chang Y, Kim SG, Cho J, Guallar E. Serum uric acid levels predict incident nonalcoholic fatty liver disease in healthy Korean men. Metabolism. 2011;60:860-866. [PMID: 20863537 DOI: 10.1016/j.metabol.2010.08.005] [Cited by in Crossref: 57] [Cited by in F6Publishing: 50] [Article Influence: 4.8] [Reference Citation Analysis]
53 Targher G, Bertolini L, Rodella S, Lippi G, Zoppini G, Chonchol M. Relationship between kidney function and liver histology in subjects with nonalcoholic steatohepatitis. Clin J Am Soc Nephrol 2010;5:2166-71. [PMID: 20724519 DOI: 10.2215/CJN.05050610] [Cited by in Crossref: 128] [Cited by in F6Publishing: 53] [Article Influence: 10.7] [Reference Citation Analysis]
54 Wilechansky RM, Pedley A, Massaro JM, Hoffmann U, Benjamin EJ, Long MT. Relations of liver fat with prevalent and incident chronic kidney disease in the Framingham Heart Study: A secondary analysis. Liver Int 2019;39:1535-44. [PMID: 31033142 DOI: 10.1111/liv.14125] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
55 Yilmaz MI, Turgut F, Kanbay M, Saglam M, Sonmez A, Yaman H, Demirbas S, Unal HU, Gok M, Karaman M, Ay SA, Demirkaya E, Covic A, Carrero JJ. Serum gamma-glutamyltransferase levels are inversely related to endothelial function in chronic kidney disease. Int Urol Nephrol 2013;45:1071-8. [PMID: 23242503 DOI: 10.1007/s11255-012-0354-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
56 Hashimoto Y, Hamaguchi M, Okamura T, Nakanishi N, Obora A, Kojima T, Fukui M. Metabolic associated fatty liver disease is a risk factor for chronic kidney disease. J Diabetes Investig 2021. [PMID: 34561962 DOI: 10.1111/jdi.13678] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
57 Mantovani A, Petracca G, Beatrice G, Csermely A, Lonardo A, Schattenberg JM, Tilg H, Byrne CD, Targher G. Non-alcoholic fatty liver disease and risk of incident chronic kidney disease: an updated meta-analysis. Gut. 2020;. [PMID: 33303564 DOI: 10.1136/gutjnl-2020-323082] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 9.5] [Reference Citation Analysis]
58 Bulum T, Kolarić B, Duvnjak M, Duvnjak L. Alkaline phosphatase is independently associated with renal function in normoalbuminuric type 1 diabetic patients. Ren Fail 2014;36:372-7. [PMID: 24455970 DOI: 10.3109/0886022X.2013.872569] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
59 Ndrepepa G, Colleran R, Kastrati A. Gamma-glutamyl transferase and the risk of atherosclerosis and coronary heart disease. Clinica Chimica Acta 2018;476:130-8. [DOI: 10.1016/j.cca.2017.11.026] [Cited by in Crossref: 44] [Cited by in F6Publishing: 38] [Article Influence: 11.0] [Reference Citation Analysis]
60 El Azeem HA, Khalek el-SA, El-Akabawy H, Naeim H, Khalik HA, Alfifi AA. Association between nonalcoholic fatty liver disease and the incidence of cardiovascular and renal events. J Saudi Heart Assoc. 2013;25:239-246. [PMID: 24198448 DOI: 10.1016/j.jsha.2013.07.004] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 3.0] [Reference Citation Analysis]
61 Sreeram M, Suryakar AN, Dani NH. Is gamma-glutamyl transpeptidase a biomarker for oxidative stress in periodontitis? J Indian Soc Periodontol 2015;19:150-4. [PMID: 26015663 DOI: 10.4103/0972-124X.149032] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
62 Mikolasevic I, Milic S, Turk Wensveen T, Grgic I, Jakopcic I, Stimac D, Wensveen F, Orlic L. Nonalcoholic fatty liver disease - A multisystem disease? World J Gastroenterol 2016; 22(43): 9488-9505 [PMID: 27920470 DOI: 10.3748/wjg.v22.i43.9488] [Cited by in CrossRef: 91] [Cited by in F6Publishing: 85] [Article Influence: 15.2] [Reference Citation Analysis]
63 Hashimoto Y, Hamaguchi M, Fukuda T, Obora A, Kojima T, Fukui M. Weight gain since age of 20 as risk of metabolic syndrome even in non-overweight individuals. Endocrine 2017;58:253-61. [DOI: 10.1007/s12020-017-1411-5] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 2.6] [Reference Citation Analysis]
64 Hashimoto Y, Okamura T, Hamaguchi M, Obora A, Kojima T, Fukui M. Impact of respiratory function on the progression from metabolically healthy non-overweight to metabolically abnormal phenotype. Nutrition, Metabolism and Cardiovascular Diseases 2018;28:922-8. [DOI: 10.1016/j.numecd.2018.05.016] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
65 Kitae A, Hashimoto Y, Hamaguchi M, Obora A, Kojima T, Fukui M. The Triglyceride and Glucose Index Is a Predictor of Incident Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study. Can J Gastroenterol Hepatol 2019;2019:5121574. [PMID: 31687367 DOI: 10.1155/2019/5121574] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
66 Targher G, Chonchol M, Bertolini L, Rodella S, Zenari L, Lippi G, Franchini M, Zoppini G, Muggeo M. Increased risk of CKD among type 2 diabetics with nonalcoholic fatty liver disease. J Am Soc Nephrol. 2008;19:1564-1570. [PMID: 18385424 DOI: 10.1681/asn.2007101155] [Cited by in Crossref: 122] [Cited by in F6Publishing: 51] [Article Influence: 8.7] [Reference Citation Analysis]
67 Kunutsor SK, Laukkanen JA. Gamma-glutamyltransferase and risk of chronic kidney disease: A prospective cohort study. Clin Chim Acta. 2017;473:39-44. [PMID: 28811239 DOI: 10.1016/j.cca.2017.08.014] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
68 Kiapidou S, Liava C, Kalogirou M, Akriviadis E, Sinakos E. Chronic kidney disease in patients with non-alcoholic fatty liver disease: What the Hepatologist should know? Ann Hepatol 2020;19:134-44. [PMID: 31606352 DOI: 10.1016/j.aohep.2019.07.013] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
69 Yang W, Kim CK, Kim DY, Jeong H, Lee S. Gamma-glutamyl transferase predicts future stroke: A Korean nationwide study: GGT Predicts Future Stroke. Ann Neurol 2018;83:375-86. [DOI: 10.1002/ana.25158] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
70 Okamura T, Hashimoto Y, Hamaguchi M, Obora A, Kojima T, Fukui M. Effect of alcohol consumption and the presence of fatty liver on the risk for incident type 2 diabetes: a population-based longitudinal study. BMJ Open Diabetes Res Care 2020;8:e001629. [PMID: 32900699 DOI: 10.1136/bmjdrc-2020-001629] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
71 Okamura T, Hashimoto Y, Hamaguchi M, Obora A, Kojima T, Fukui M. Visceral Adiposity Index is a predictor of incident colorectal cancer: a population-based longitudinal study. BMJ Open Gastroenterol 2020;7:e000400. [PMID: 32595114 DOI: 10.1136/bmjgast-2020-000400] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
72 Hu MC, Shi M, Zhang J, Quiñones H, Griffith C, Kuro-o M, Moe OW. Klotho deficiency causes vascular calcification in chronic kidney disease. J Am Soc Nephrol 2011;22:124-36. [PMID: 21115613 DOI: 10.1681/ASN.2009121311] [Cited by in Crossref: 578] [Cited by in F6Publishing: 330] [Article Influence: 48.2] [Reference Citation Analysis]
73 Okamura T, Hashimoto Y, Hamaguchi M, Obora A, Kojima T, Fukui M. The visceral adiposity index is a predictor of incident nonalcoholic fatty liver disease: A population-based longitudinal study. Clinics and Research in Hepatology and Gastroenterology 2020;44:375-83. [DOI: 10.1016/j.clinre.2019.04.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
74 Hamaguchi M, Obora A, Okamura T, Hashimoto Y, Kojima T, Fukui M. Changes in metabolic complications in patients with alcoholic fatty liver disease monitored over two decades: NAGALA study. BMJ Open Gastroenterol 2020;7:e000359. [PMID: 32337056 DOI: 10.1136/bmjgast-2019-000359] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
75 Hashimoto Y, Hamaguchi M, Fukuda T, Nakamura N, Ohbora A, Kojima T, Fukui M. BMI history and risk of incident fatty liver: a population-based large-scale cohort study. Eur J Gastroenterol Hepatol. 2016;28:1188-1193. [PMID: 27347789 DOI: 10.1097/meg.0000000000000682] [Cited by in Crossref: 15] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
76 Hashimoto Y, Hamaguchi M, Kojima T, Ohshima Y, Ohbora A, Kato T, Nakamura N, Fukui M. Modest alcohol consumption reduces the incidence of fatty liver in men: a population-based large-scale cohort study. J Gastroenterol Hepatol 2015;30:546-52. [PMID: 25238605 DOI: 10.1111/jgh.12786] [Cited by in Crossref: 59] [Cited by in F6Publishing: 52] [Article Influence: 8.4] [Reference Citation Analysis]
77 Völzke H, Alte D, Ittermann T, Schmidt CO, Rettig R, Mayerle J, Lowenfels AB, Lerch MM, Nauck M. Subjects with sonographical hepatic steatosis should be excluded from studies to establish upper reference levels of serum transaminases. Liver Int 2011;31:985-93. [PMID: 21078068 DOI: 10.1111/j.1478-3231.2010.02371.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
78 Targher G. Elevated serum gamma-glutamyltransferase activity is associated with increased risk of mortality, incident type 2 diabetes, cardiovascular events, chronic kidney disease and cancer - a narrative review. Clin Chem Lab Med. 2010;48:147-157. [PMID: 19943812 DOI: 10.1515/cclm.2010.031] [Cited by in Crossref: 67] [Cited by in F6Publishing: 42] [Article Influence: 5.6] [Reference Citation Analysis]
79 Targher G, Kendrick J, Smits G, Chonchol M. Relationship between serum gamma-glutamyltransferase and chronic kidney disease in the United States adult population. Findings from the National Health and Nutrition Examination Survey 2001-2006. Nutr Metab Cardiovasc Dis. 2010;20:583-590. [PMID: 19699624 DOI: 10.1016/j.numecd.2009.05.012] [Cited by in Crossref: 40] [Cited by in F6Publishing: 41] [Article Influence: 3.1] [Reference Citation Analysis]
80 Hu MC, Kuro-o M, Moe OW. Secreted klotho and chronic kidney disease. Adv Exp Med Biol 2012;728:126-57. [PMID: 22396167 DOI: 10.1007/978-1-4614-0887-1_9] [Cited by in Crossref: 79] [Cited by in F6Publishing: 75] [Article Influence: 7.9] [Reference Citation Analysis]
81 Fukuda T, Hamaguchi M, Kojima T, Mitsuhashi K, Hashimoto Y, Ohbora A, Kato T, Nakamura N, Fukui M. Transient remission of nonalcoholic fatty liver disease decreases the risk of incident type 2 diabetes mellitus in Japanese men. Eur J Gastroenterol Hepatol. 2016;28:1443-1449. [PMID: 27603300 DOI: 10.1097/meg.0000000000000736] [Cited by in Crossref: 25] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
82 Okamura T, Hashimoto Y, Hamaguchi M, Obora A, Kojima T, Fukui M. Clinical characteristics and longitudinal changes of patients with non-alcoholic fatty liver disease in 2 decades: the NAGALA study. BMC Gastroenterol 2021;21:223. [PMID: 34001028 DOI: 10.1186/s12876-021-01809-2] [Reference Citation Analysis]
83 Mason JE, Starke RD, Van Kirk JE. Gamma-glutamyl transferase: a novel cardiovascular risk biomarker. Prev Cardiol. 2010;13:36-41. [PMID: 20021625 DOI: 10.1111/j.1751-7141.2009.00054.x] [Cited by in Crossref: 125] [Cited by in F6Publishing: 105] [Article Influence: 10.4] [Reference Citation Analysis]
84 Targher G, Chonchol MB, Byrne CD. CKD and nonalcoholic fatty liver disease. Am J Kidney Dis. 2014;64:638-652. [PMID: 25085644 DOI: 10.1053/j.ajkd.2014.05.019] [Cited by in Crossref: 104] [Cited by in F6Publishing: 96] [Article Influence: 13.0] [Reference Citation Analysis]
85 Ishigami T, Yamamoto R, Nagasawa Y, Isaka Y, Rakugi H, Iseki K, Yamagata K, Tsuruya K, Yoshida H, Fujimoto S, Asahi K, Kurahashi I, Ohashi Y, Moriyama T, Watanabe T. An association between serum γ-glutamyltransferase and proteinuria in drinkers and non-drinkers: a Japanese nationwide cross-sectional survey. Clin Exp Nephrol 2014;18:899-910. [PMID: 24493465 DOI: 10.1007/s10157-014-0938-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
86 Liu EQ, Weng YP, Zhou AM, Zeng CL. Association between Triglyceride-Glucose Index and Type 2 Diabetes Mellitus in the Japanese Population: A Secondary Analysis of a Retrospective Cohort Study. Biomed Res Int 2020;2020:2947067. [PMID: 33490240 DOI: 10.1155/2020/2947067] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
87 Ryu S, Chang Y, Zhang Y, Kim S, Cho J, Son HJ, Shin H, Guallar E. A Cohort Study of Hyperuricemia in Middle-aged South Korean Men. American Journal of Epidemiology 2012;175:133-43. [DOI: 10.1093/aje/kwr291] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 3.2] [Reference Citation Analysis]
88 Chang Y, Ryu S, Zhang Y, Son HJ, Kim JY, Cho J, Guallar E. A cohort study of serum bilirubin levels and incident non-alcoholic fatty liver disease in middle aged Korean workers. PLoS One. 2012;7:e37241. [PMID: 22615952 DOI: 10.1371/journal.pone.0037241] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 3.2] [Reference Citation Analysis]
89 Wang Z, Hoy WE. The predictive value of albuminuria for renal and nonrenal natural deaths over 14 years follow-up in a remote aboriginal community. Clin Kidney J 2012;5:519-25. [PMID: 26064480 DOI: 10.1093/ckj/sfs125] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
90 Targher G, Bertolini L, Chonchol M, Rodella S, Zoppini G, Lippi G, Zenari L, Bonora E. Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and retinopathy in type 1 diabetic patients. Diabetologia. 2010;53:1341-1348. [PMID: 20369224 DOI: 10.1007/s00125-010-1720-1] [Cited by in Crossref: 94] [Cited by in F6Publishing: 87] [Article Influence: 7.8] [Reference Citation Analysis]
91 Jung DH, Lee YJ, Lee HR, Lee JH, Shim JY. Association of renal manifestations with serum uric acid in Korean adults with normal uric acid levels. J Korean Med Sci 2010;25:1766-70. [PMID: 21165292 DOI: 10.3346/jkms.2010.25.12.1766] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
92 Heda R, Yazawa M, Shi M, Bhaskaran M, Aloor FZ, Thuluvath PJ, Satapathy SK. Non-alcoholic fatty liver and chronic kidney disease: Retrospect, introspect, and prospect. World J Gastroenterol 2021; 27(17): 1864-1882 [PMID: 34007127 DOI: 10.3748/wjg.v27.i17.1864] [Cited by in CrossRef: 1] [Article Influence: 1.0] [Reference Citation Analysis]
93 Koenig G, Seneff S. Gamma-Glutamyltransferase: A Predictive Biomarker of Cellular Antioxidant Inadequacy and Disease Risk. Dis Markers. 2015;2015:818570. [PMID: 26543300 DOI: 10.1155/2015/818570] [Cited by in Crossref: 100] [Cited by in F6Publishing: 99] [Article Influence: 14.3] [Reference Citation Analysis]
94 Noborisaka Y, Ishizaki M, Yamazaki M, Honda R, Yamada Y. Elevated Blood Pressure and Serum γ -Glutamyltransferase as Significant Characteristics of Smokers With Chronic Kidney Disease. Nephrourol Mon 2014;6:e20746. [PMID: 25695028 DOI: 10.5812/numonthly.20746] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
95 Ryu S, Chang Y, Woo H, Yoo S, Choi N, Lee W, Kim I, Song J. Longitudinal increase in γ-glutamyltransferase within the reference interval predicts metabolic syndrome in middle-aged Korean men. Metabolism 2010;59:683-9. [DOI: 10.1016/j.metabol.2009.08.024] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 2.0] [Reference Citation Analysis]
96 Nakajima H, Hashimoto Y, Kaji A, Sakai R, Takahashi F, Yoshimura Y, Bamba R, Okamura T, Kitagawa N, Majima S, Senmaru T, Okada H, Nakanishi N, Ushigome E, Asano M, Hamaguchi M, Yamazaki M, Fukui M. Impact of extracellular-to-intracellular fluid volume ratio on albuminuria in patients with type 2 diabetes: A cross-sectional and longitudinal cohort study. J Diabetes Investig 2021;12:1202-11. [PMID: 33145975 DOI: 10.1111/jdi.13459] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
97 Liu YR, Tang ZS, Duan JA, Chen L, Sun J, Zhou R, Song ZX, Shi XB, Zhu HY. ER-depletion lowering the 'hypothalamus-uterus-kidney' axis functions by perturbing the renal ERβ/Ptgds signalling pathway. Aging (Albany NY) 2019;11:9500-29. [PMID: 31708494 DOI: 10.18632/aging.102401] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
98 Hamaguchi M, Kojima T, Ohbora A, Takeda N, Fukui M, Kato T. Protective effect of alcohol consumption for fatty liver but not metabolic syndrome. World J Gastroenterol 2012; 18(2): 156-167 [PMID: 22253522 DOI: 10.3748/wjg.v18.i2.156] [Cited by in CrossRef: 52] [Cited by in F6Publishing: 50] [Article Influence: 5.2] [Reference Citation Analysis]
99 Kunutsor SK. Gamma-glutamyltransferase-friend or foe within? Liver Int 2016;36:1723-34. [DOI: 10.1111/liv.13221] [Cited by in Crossref: 52] [Cited by in F6Publishing: 50] [Article Influence: 8.7] [Reference Citation Analysis]
100 Targher G, Pichiri I, Zoppini G, Trombetta M, Bonora E. Increased prevalence of chronic kidney disease in patients with Type 1 diabetes and non-alcoholic fatty liver. Diabet Med. 2012;29:220-226. [PMID: 21883436 DOI: 10.1111/j.1464-5491.2011.03427.x] [Cited by in Crossref: 43] [Cited by in F6Publishing: 42] [Article Influence: 4.3] [Reference Citation Analysis]
101 Ochiai H, Shirasawa T, Yoshimoto T, Nagahama S, Watanabe A, Sakamoto K, Kokaze A. Elevated alanine aminotransferase and low aspartate aminotransferase/alanine aminotransferase ratio are associated with chronic kidney disease among middle-aged women: a cross-sectional study. BMC Nephrol 2020;21:471. [PMID: 33172399 DOI: 10.1186/s12882-020-02144-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
102 Lee J, Yoon K, Ryu S, Chang Y, Kim HR. High-normal levels of hs-CRP predict the development of non-alcoholic fatty liver in healthy men. PLoS One 2017;12:e0172666. [PMID: 28234943 DOI: 10.1371/journal.pone.0172666] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 4.4] [Reference Citation Analysis]
103 Ryu S, Chang Y, Zhang Y, Woo HY, Kwon MJ, Park H, Lee KB, Son HJ, Cho J, Guallar E. Higher serum direct bilirubin levels were associated with a lower risk of incident chronic kidney disease in middle aged Korean men. PLoS One 2014;9:e75178. [PMID: 24586219 DOI: 10.1371/journal.pone.0075178] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
104 Lee CH, Han K, Kim DH, Kwak MS. Repeatedly elevated γ-glutamyltransferase levels are associated with an increased incidence of digestive cancers: A population-based cohort study. World J Gastroenterol 2021; 27(2): 176-188 [PMID: 33510558 DOI: 10.3748/wjg.v27.i2.176] [Reference Citation Analysis]
105 Franzini M, Corti A, Fornaciari I, Balderi M, Torracca F, Lorenzini E, Baggiani A, Pompella A, Emdin M, Paolicchi A. Cultured human cells release soluble gamma-glutamyltransferase complexes corresponding to the plasma b-GGT. Biomarkers. 2009;14:486-492. [PMID: 19863187 DOI: 10.3109/13547500903093757] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
106 Noborisaka Y, Ishizaki M, Yamazaki M, Honda R, Yamada Y. Elevated Serum Gamma-Glutamyltransferase (GGT) Activity and the Development of Chronic Kidney Disease (CKD) in Cigarette Smokers. Nephrourol Mon 2013;5:967-73. [PMID: 24693503 DOI: 10.5812/numonthly.13652] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
107 Lee DY, Han K, Yu JH, Park S, Heo JI, Seo JA, Kim NH, Yoo HJ, Kim SG, Kim SM, Choi KM, Baik SH, Park YG, Kim NH. Gamma-glutamyl transferase variability can predict the development of end-stage of renal disease: a nationwide population-based study. Sci Rep 2020;10:11668. [PMID: 32669624 DOI: 10.1038/s41598-020-68603-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
108 Park H, Dawwas GK, Liu X, Nguyen MH. Nonalcoholic fatty liver disease increases risk of incident advanced chronic kidney disease: a propensity-matched cohort study. J Intern Med. 2019;286:711-722. [PMID: 31359543 DOI: 10.1111/joim.12964] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 7.7] [Reference Citation Analysis]
109 Shang L, Li R, Zhao Y, Sun H, Tang B, Hou Y. Association Between Chinese Visceral Adiposity Index and Incident Type 2 Diabetes Mellitus in Japanese Adults. Diabetes Metab Syndr Obes 2021;14:3743-51. [PMID: 34466009 DOI: 10.2147/DMSO.S322935] [Reference Citation Analysis]
110 Ryu S, Chang Y, Woo HY, Lee KB, Kim SG, Kim DI, Kim WS, Suh BS, Jeong C, Yoon K. Time-dependent association between metabolic syndrome and risk of CKD in Korean men without hypertension or diabetes. Am J Kidney Dis. 2009;53:59-69. [PMID: 18838200 DOI: 10.1053/j.ajkd.2008.07.027] [Cited by in Crossref: 58] [Cited by in F6Publishing: 51] [Article Influence: 4.1] [Reference Citation Analysis]
111 Okamura T, Hashimoto Y, Hamaguchi M, Obora A, Kojima T, Fukui M. Triglyceride-glucose index (TyG index) is a predictor of incident colorectal cancer: a population-based longitudinal study. BMC Endocr Disord 2020;20:113. [PMID: 32709256 DOI: 10.1186/s12902-020-00581-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
112 Hashimoto Y, Hamaguchi M, Nakanishi N, Ohbora A, Kojima T, Fukui M. Urinary pH is a predictor of diabetes in men; a population based large scale cohort study. Diabetes Res Clin Pract. 2017;130:9-14. [PMID: 28551482 DOI: 10.1016/j.diabres.2017.04.023] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
113 Salai Bojan M, Rajappa R, Vijayakumar DRK, Gopalan J. Protective effect of Raphanus sativus on D-galactosamine induced nephrotoxicity in rats. Nutrition Clinique et Métabolisme 2016;30:22-8. [DOI: 10.1016/j.nupar.2015.12.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
114 Shibata M, Sato KK, Uehara S, Koh H, Oue K, Kambe H, Morimoto M, Hayashi T. Serum Gamma-Glutamyltransferase, Daily Alcohol Consumption, and the Risk of Chronic Kidney Disease: The Kansai Healthcare Study. J Epidemiol 2020;30:163-9. [PMID: 30930374 DOI: 10.2188/jea.JE20180240] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
115 Lee DH, Gross MD, Steffes MW, Jacobs DR Jr. Is serum gamma-glutamyltransferase a biomarker of xenobiotics, which are conjugated by glutathione? Arterioscler Thromb Vasc Biol 2008;28:e26-8; author reply e29. [PMID: 18354088 DOI: 10.1161/ATVBAHA.107.159376] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
116 Orlić L, Mikolasevic I, Bagic Z, Racki S, Stimac D, Milic S. Chronic kidney disease and nonalcoholic Fatty liver disease-is there a link? Gastroenterol Res Pract 2014;2014:847539. [PMID: 24729784 DOI: 10.1155/2014/847539] [Cited by in Crossref: 30] [Cited by in F6Publishing: 33] [Article Influence: 3.8] [Reference Citation Analysis]
117 Mantovani A, Zaza G, Byrne CD, Lonardo A, Zoppini G, Bonora E, Targher G. Nonalcoholic fatty liver disease increases risk of incident chronic kidney disease: A systematic review and meta-analysis. Metabolism. 2018;79:64-76. [PMID: 29137912 DOI: 10.1016/j.metabol.2017.11.003] [Cited by in Crossref: 131] [Cited by in F6Publishing: 118] [Article Influence: 26.2] [Reference Citation Analysis]
118 Fukuda T, Hamaguchi M, Kojima T, Ohshima Y, Ohbora A, Kato T, Nakamura N, Fukui M. Association between serum γ-glutamyltranspeptidase and atherosclerosis: a population-based cross-sectional study. BMJ Open 2014;4:e005413. [PMID: 25280803 DOI: 10.1136/bmjopen-2014-005413] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
119 Musso G, Gambino R, Tabibian JH, Ekstedt M, Kechagias S, Hamaguchi M, Hultcrantz R, Hagström H, Yoon SK, Charatcharoenwitthaya P, George J, Barrera F, Hafliðadóttir S, Björnsson ES, Armstrong MJ, Hopkins LJ, Gao X, Francque S, Verrijken A, Yilmaz Y, Lindor KD, Charlton M, Haring R, Lerch MM, Rettig R, Völzke H, Ryu S, Li G, Wong LL, Machado M, Cortez-Pinto H, Yasui K, Cassader M. Association of non-alcoholic fatty liver disease with chronic kidney disease: a systematic review and meta-analysis. PLoS Med 2014;11:e1001680. [PMID: 25050550 DOI: 10.1371/journal.pmed.1001680] [Cited by in Crossref: 283] [Cited by in F6Publishing: 269] [Article Influence: 35.4] [Reference Citation Analysis]
120 Osaka T, Hashimoto Y, Hamaguchi M, Kojima T, Obora A, Fukui M. Nonalcoholic fatty liver disease remission in men through regular exercise. J Clin Biochem Nutr 2018;62:242-6. [PMID: 29892163 DOI: 10.3164/jcbn.17-115] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
121 Fukuda Y, Hashimoto Y, Hamaguchi M, Fukuda T, Nakamura N, Ohbora A, Kato T, Kojima T, Fukui M. Triglycerides to high-density lipoprotein cholesterol ratio is an independent predictor of incident fatty liver; a population-based cohort study. Liver Int. 2016;36:713-720. [PMID: 26444696 DOI: 10.1111/liv.12977] [Cited by in Crossref: 45] [Cited by in F6Publishing: 42] [Article Influence: 6.4] [Reference Citation Analysis]
122 Ko SH, Baeg MK, Han KD, Ko SY, Shin SB, Ko SH, Ahn YB. Association between gamma-glutamyltransferase and albuminuria in nondiabetic adults with normal renal function. Clin Exp Nephrol 2017;21:835-41. [PMID: 27933415 DOI: 10.1007/s10157-016-1356-7] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
123 Lee DH, Steffes MW, Jacobs DR Jr. Can persistent organic pollutants explain the association between serum gamma-glutamyltransferase and type 2 diabetes? Diabetologia 2008;51:402-7. [PMID: 18071669 DOI: 10.1007/s00125-007-0896-5] [Cited by in Crossref: 58] [Cited by in F6Publishing: 49] [Article Influence: 3.9] [Reference Citation Analysis]
124 Okamura T, Hashimoto Y, Hamaguchi M, Obora A, Kojima T, Fukui M. Ectopic fat obesity presents the greatest risk for incident type 2 diabetes: a population-based longitudinal study. Int J Obes (Lond) 2019;43:139-48. [PMID: 29717276 DOI: 10.1038/s41366-018-0076-3] [Cited by in Crossref: 50] [Cited by in F6Publishing: 49] [Article Influence: 12.5] [Reference Citation Analysis]
125 Ahn AL, Choi JK, Kim MN, Kim SA, Oh EJ, Kweon HJ, Cho DY. Non-alcoholic Fatty Liver Disease and Chronic Kidney Disease in Koreans Aged 50 Years or Older. Korean J Fam Med. 2013;34:199-205. [PMID: 23730487 DOI: 10.4082/kjfm.2013.34.3.199] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 2.0] [Reference Citation Analysis]
126 Okamura T, Hashimoto Y, Hamaguchi M, Obora A, Kojima T, Fukui M. Creatinine-to-bodyweight ratio is a predictor of incident non-alcoholic fatty liver disease: A population-based longitudinal study. Hepatol Res 2020;50:57-66. [PMID: 31692179 DOI: 10.1111/hepr.13429] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
127 Pscheidt C, Nagel G, Zitt E, Kramar R, Concin H, Lhotta K. Sex- and Time-Dependent Patterns in Risk Factors of End-Stage Renal Disease: A Large Austrian Cohort with up to 20 Years of Follow-Up. PLoS One 2015;10:e0135052. [PMID: 26322515 DOI: 10.1371/journal.pone.0135052] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.7] [Reference Citation Analysis]